|52.15||+0.37 / +0.71%|
Data as of Oct 21
|52.85||+0.70 / +1.34%|
The 25 analysts offering 12-month price forecasts for Sanofi SA have a median target of 58.24, with a high estimate of 68.94 and a low estimate of 49.24. The median estimate represents a +11.68% increase from the last price of 52.15.
The current consensus among 28 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.